XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Revenue $ 166,911 $ 59,738 $ 441,738 $ 159,992
Cost of revenue 37,342 15,434 101,563 41,513
Gross profit 129,569 44,304 340,175 118,479
Operating expenses        
Research and development 60,230 22,286 154,656 60,558
Sales and marketing 92,065 15,190 235,194 42,272
General and administrative 60,457 22,124 183,788 58,897
Total operating expenses 212,752 59,600 573,638 161,727
Loss from operations (83,183) (15,296) (233,463) (43,248)
Other expenses, net (4,416) (11,432) (12,891) (13,943)
Loss before benefit from income taxes (87,599) (26,728) (246,354) (57,191)
Benefit from income taxes (879)   (4,935) (333)
Net loss $ (86,720) $ (26,728) $ (241,419) $ (56,858)
Net loss per share attributable to common stockholders:        
Basic and diluted $ (0.84) $ (0.32) $ (2.39) $ (0.70)
Weighted-average number of common shares used to compute net loss per share attributable to common stockholders:        
Basic and diluted 103,830 82,627 100,856 81,446